Evidence map›Paper›PMID 31650076›Full record

ArticleContemporary clinical trials communications2019

Design and outcome measures for the AB InBev Global Smart Drinking Goals evaluation.

Ted R Miller, Christopher L Ringwalt, Joel W Grube, Mallie J Paschall, Deborah A Fisher, Mary V Gordon

Abstract read
In one paragraph

Article in Contemporary clinical trials communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Predictors of Engagement and Attendance of a Family-Based Prevention Program for Underage Drinking in Mexico.Prevention science : the official journal of the Society for Prevention Research · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ted R MillerHBSA, 11720 Beltsville Drive, Suite 900, Calverton, MD, 20705, USA.
Christopher L RingwaltHBSA, 11720 Beltsville Drive, Suite 900, Calverton, MD, 20705, USA.
Joel W GrubeHBSA, 11720 Beltsville Drive, Suite 900, Calverton, MD, 20705, USA.
Mallie J PaschallHBSA, 11720 Beltsville Drive, Suite 900, Calverton, MD, 20705, USA.
Deborah A FisherHBSA, 11720 Beltsville Drive, Suite 900, Calverton, MD, 20705, USA.
Mary V GordonHBSA, 11720 Beltsville Drive, Suite 900, Calverton, MD, 20705, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the rationale for and design of an independent evaluation of the Global Smart Drinking Goals (GSDG) program. The primary purpose of this program, supported by the AB InBev Foundation, is to reduce harms associated with alcohol use by 10%. Our evaluation focuses on the effects of prevention strategies sponsored by the Foundation that are being implemented in six city pilots located in as many countries. These strategies are designed to reduce heavy episodic drinking, underage drinking, drink driving, and alcohol-related violence. Each city pilot has been matched with a comparison city in which the GSDG program will not be implemented. In this quasi-experimental community trial, we will assess each city pilot's progress toward reaching its harm reduction goals, relative to its comparison city, by means of annual adult and youth surveys. We will then supplement these analyses with the use of pertinent local archival data, where available. We discuss several challenges related to this evaluation and its quasi-experimental design. These include operating in a fluid and unpredictable environment in regard to the implementation, adaptation, and (on occasion) abandonment of the prevention strategies selected by each city pilot. We also discuss issues concerning our decision to accept funding from the alcohol industry and the measures we have taken to ensure the independence of our evaluation.

Indexed as

AlcoholCommunity trialEvaluation designHarm prevention

Identifiers

PMID31650076
PMCPMC6804502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.